These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 16171491)

  • 1. Re: Prediction of the fetal Kell blood group reduces aggressive interventions.
    Araújo F; Monteiro F; Pereira C; Duran J; Nascimento H; Lima L; Cunha A; Storry J; Guimarães J
    Aust N Z J Obstet Gynaecol; 2005 Oct; 45(5):464. PubMed ID: 16171491
    [No Abstract]   [Full Text] [Related]  

  • 2. Obstetric history and antibody titer in estimating severity of Kell alloimmunization in pregnancy.
    van Wamelen DJ; Klumper FJ; de Haas M; Meerman RH; van Kamp IL; Oepkes D
    Obstet Gynecol; 2007 May; 109(5):1093-8. PubMed ID: 17470588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting anti-Kell-mediated hemolytic disease of the fetus and newborn: diagnostic accuracy of laboratory management.
    Slootweg YM; Lindenburg IT; Koelewijn JM; Van Kamp IL; Oepkes D; De Haas M
    Am J Obstet Gynecol; 2018 Oct; 219(4):393.e1-393.e8. PubMed ID: 30063902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Perinatal research on feto-maternal anti-Kell immunization].
    Gavriil P; Jauniaux E; Lambermont M; Donner C; Avni FE; Rodesch F
    J Gynecol Obstet Biol Reprod (Paris); 1989; 18(6):761-4. PubMed ID: 2689503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current clinical management of anti-Kell alloimmunization in pregnancy.
    Santiago JC; Ramos-Corpas D; Oyonarte S; Montoya F
    Eur J Obstet Gynecol Reprod Biol; 2008 Feb; 136(2):151-4. PubMed ID: 17481801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hemolytic disease of the newborn due to Kell sensitization].
    Beller U; Hochner-Celnikier D; Ron M; Palti Z; Beyth Y
    Harefuah; 1981 Jul; 101(1-2):14-5. PubMed ID: 7319365
    [No Abstract]   [Full Text] [Related]  

  • 7. [Kell antibodies in pregnancy].
    Rempen A; Schweppe KW
    Z Geburtshilfe Perinatol; 1983; 187(4):183-90. PubMed ID: 6684844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
    Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
    Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Haemolytic disease of the newborn--from a mother with anti-Kell, anti-E and anti-Vel anti-erythrocyte alloantibodies].
    Vućinović M; Jadrić H; Karelović D; Roje D; Haspl-Hundrić Z; Hrgović Z; Vućinović Z
    Z Geburtshilfe Neonatol; 2004 Oct; 208(5):197-202. PubMed ID: 15508054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythropoietic suppression in fetal anemia because of Kell alloimmunization.
    Vaughan JI; Warwick R; Letsky E; Nicolini U; Rodeck CH; Fisk NM
    Am J Obstet Gynecol; 1994 Jul; 171(1):247-52. PubMed ID: 8030708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Death in utero due to Kell sensitization without excessive elevation of the delta OD450 value in amniotic fluid.
    Berkowitz RL; Beyth Y; Sadovsky E
    Obstet Gynecol; 1982 Dec; 60(6):746-9. PubMed ID: 7145281
    [No Abstract]   [Full Text] [Related]  

  • 12. The incidence of large fetomaternal hemorrhage and the Kleihauer-Betke test.
    Pelikan DM; Scherjon SA; Kanhai HH
    Obstet Gynecol; 2006 Jan; 107(1):206-7; author reply 207. PubMed ID: 16394063
    [No Abstract]   [Full Text] [Related]  

  • 13. [Anti-K antibodies in pregnant women and genotyping of K antigen in foetuses].
    Zupańska B; Nowaczek-Migas M; Michalewska B; Wielgoś M; Orzińska A
    Ginekol Pol; 2008 Jun; 79(6):410-4. PubMed ID: 18652128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An innovative test for non-invasive Kell genotyping on circulating fetal DNA by means of the allelic discrimination of K1 and K2 antigens.
    Cro' F; Lapucci C; Vicari E; Salsi G; Rizzo N; Farina A
    Am J Reprod Immunol; 2016 Dec; 76(6):499-503. PubMed ID: 27730708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Kell alloimmunization in pregnancy].
    Gariod S; Brossard Y; Poissonnier MH; Vuilliez B; Deutsch V; Jouk PS; Pons JC
    J Gynecol Obstet Biol Reprod (Paris); 2004 Nov; 33(7):637-48. PubMed ID: 15550883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Kell blood group system and antibodies].
    Sasaki M; Watanabe N
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():687-9. PubMed ID: 16111368
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prenatal genotyping of the RhD locus by polymerase chain reaction in fetus at risk of hemolytic disease].
    Misković B; Stipoljev F; Hadzisejdić I; Grahovac B
    Lijec Vjesn; 2008; 130(1-2):4-6. PubMed ID: 18589635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Kell blood group system].
    Endoh T; Watanabe N
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():760-3. PubMed ID: 20942182
    [No Abstract]   [Full Text] [Related]  

  • 19. Noninvasive genotyping fetal Kell blood group (KEL1) using cell-free fetal DNA in maternal plasma by MALDI-TOF mass spectrometry.
    Li Y; Finning K; Daniels G; Hahn S; Zhong X; Holzgreve W
    Prenat Diagn; 2008 Mar; 28(3):203-8. PubMed ID: 18241084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymerase-chain-reaction-based detection of fetal rhesus D and Y-chromosome-specific DNA in the whole blood of pregnant women during different trimesters of pregnancy.
    Al-Yatama MK; Mustafa AS; Al-Kandari FM; Khaja N; Zohra K; Monem RA; Abraham S
    Med Princ Pract; 2007; 16(5):327-32. PubMed ID: 17709918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.